Technical Articles
Systemic lupus erythematosus
The Biological Characteristics of Human IL-2 and IL-2R and the Clinical Application Value of Detection Kits
Interleukin-2 (IL-2) is a key cytokine with bidirectional immunomodulatory functions. In 1984, IL-2 was first applied clinically using a high-dose administration regimen to activate conventional T cells.
View details
- Immunity/Inflamma
- Human IL-2R Kit (HICA)
- Immunoregulatory function
- Systemic lupus erythematosus
The mechanism of the IL-6 pathway in systemic lupus erythematosus, its potential for targeted therapy, and evaluation tools
Systemic lupus erythematosus is a systemic autoimmune disease characterized by immune system dysregulation, which produces a large number of autoantibodies and attacks multiple organ systems, leading to widespread inflammation and tissue damage.
View details
- Immunity/Inflamma
- IL-6 protein (GMP)
- Systemic lupus erythematosus
- Immune-mediated disease
BAFF&APRIL Heterotrimer His Tag Protein: Decoding the "Dual Signals" of B Cell Survival, a Key to Autoimmunity and Lymphoma Research
The BAFF&APRIL heterotrimeric protein is an innovative recombinant tool that precisely mimics the complex signaling environment in vivo. By fusing B-cell activating factor (BAFF/BLyS) and a proliferation-inducing ligand (APRIL) in a heterotrimeric form with a histidine tag, it provides an unprecedented high-fidelity platform for studying the synergistic mechanisms of abnormal B-cell activation, survival, and antibody production.
View details
- Immunity/Inflamma
- BAFF & APRIL heterotrimer
- BAFF
- APRIL
- B cell signaling
- autoimmune diseases
- systemic lupus erythematosus
Exploration of MIF and Systemic Lupus Erythematosus: Mechanisms, Regulation, and Therapeutic Potential
Macrophage Migration Inhibition Factor (MIF) is a multifunctional cytokine that has long been considered a key regulatory molecule in both innate and adaptive immune responses.
View details
- Cancer
- MIF
- systemic lupus erythematosus
- 1















